AbbVie Inc. (ABBV) vs Silver (one troy ounce) (SILVER)
See how AbbVie Inc. and Silver (one troy ounce) differ across market data and performance, so you can decide which asset best fits your strategy.
$256.42
NYSE
AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.
View Full Page$65.43
COMEX
Silver priced in U.S. dollars represents the market value of one troy ounce of silver. Silver is both a precious metal and an industrial commodity, used in jewelry, investment products, electronics, solar panels, and other manufacturing applications. Its price is influenced by precious-metals demand, industrial activity, mine supply, investor flows, real interest rates, and the U.S. dollar. Because it has significant industrial uses, silver can be more cyclical and volatile than gold.
View Full PageKey Metrics Comparison
AbbVie Inc.ABBV
Market Cap$453.124B
Price$256.42
24h Change+0.37%
24h Volume$4.24M
Employees57,000
Shares Outstanding1,768,169,012
Silver (one troy ounce)SILVER
Market Cap$3.664T
Price$65.43
24h Change-2.33%
24h Volume$15.8K
EmployeesN/A
Shares OutstandingN/A
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
ABBV
11.0%SILVER
89.0%Volume Share
Share of combined 24h volume
ABBV
99.6%SILVER
1.0%24h Performance
Price change over last 24 hours
ABBV
0.37%SILVER
-2.33%Price Comparison
AbbVie Inc.
Silver (one troy ounce)